Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Motexafin gadolinium |
Synonyms | |
Therapy Description |
Motexafin gadolinium (Gd-Tex) creates reactive oxygen specieses in tumor cells, thereby sensitizing the cells to radiation and chemotherapy (PMID: 27377046, PMID: 3235578). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Motexafin gadolinium | Xcytrin | gadolinium texaphyrin|PCI-0120|API-GP3|Gd-Tex | Motexafin gadolinium (Gd-Tex) creates reactive oxygen specieses in tumor cells, thereby sensitizing the cells to radiation and chemotherapy (PMID: 27377046, PMID: 3235578). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT00717587 | Phase II | Sunitinib Girentuximab Motexafin gadolinium | Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer | Unknown status | USA | 0 |